BioGaia’s probiotic shown to promote growth and prevent recurrent diarrhea
Results from a randomized, controlled pilot study in 71 infants with acute diarrhea show that rapid diagnostic testing and Lactobacillus reuteri Protectis supplementation for 60 days was associated with a significant increase in height and significantly less recurrent diarrhea compared to standard care and placebo treatment. The study, conducted in Botswana, is the first randomized probiotic trial in Southern Africa studying treatment of acute gastroenteritis.“These results are very exciting. Our trial has shown that the administration of L. reuteri DSM 17938 shows real promise to mitigate